Deal

BIO-RAD LABORATORIES, INC. acquires DiaMed Benelux

July 2012 full acquisition ready

Snapshot

BIO-RAD LABORATORIES, INC. acquired DiaMed Benelux for 4.6 million Euros (approximately $5.6 million) in cash in July 2012. The transaction was structured as all cash. DiaMed Benelux is a Benelux (Belgium / Netherlands / Luxembourg)-based Clinical Diagnostics business.

Acquirer
BIO-RAD LABORATORIES, INC.
Target
DiaMed Benelux
Value
4.6 million Euros (approximately $5.6 million) in cash
Date
July 2012
Type
full acquisition
Status
ready
01 Scorecard

The deal at a glance

Private-market deal
BIO-RAD LABORATORIES, INC. acquires DiaMed Benelux
Deal value
4.6 million Euros (approximately $5.6 million) in cash
Sector
Clinical Diagnostics
Date
July 2012
VectorShift
Made on VectorShift

About this deal

BIO-RAD LABORATORIES, INC. acquired DiaMed Benelux for 4.6 million Euros (approximately $5.6 million) in cash, a transaction completed in July 2012, structured as all cash.

DiaMed Benelux operates in Clinical Diagnostics, is based in Benelux (Belgium / Netherlands / Luxembourg). In July 2012, Bio-Rad acquired all of the outstanding shares of DiaMed Benelux, extending its DiaMed blood-typing diagnostics franchise in the Benelux region.

Clinical Diagnostics segment

In July 2012, we acquired all of the outstanding shares of DiaMed Benelux for 4.6 million Euros (approximately $5.6 million) in cash.
Bio-Rad Laboratories FY2014 10-K, acquisitions disclosure
Advisors not disclosed

No advisory firms have been disclosed for this transaction.

Sources Press release Last updated

See how VectorShift works for your firm

Request Demo